About Us



Photo LWang
Laurene Wang, PhD
CEO and Founder

 AimMax® Therapeutics, Inc. (AimMax), is a  company engaging in the research and development of biopharmaceuticals at various stages through in-licensing or co-development with strategic partners.

The company was founded in 2017 by pharmaceutical R&D professionals with diverse and synergistic backgrounds.




Company Core Strengths

  • Translational Medicine:  To advance early-stage molecules, from lead optimization to clinical proof of principle by understanding the molecules, the science and disease models
  • Clinical Trial Design and Operations:   To incorporate innovative trial design and data analysis to maximize clinical trial efficiency and the success of pivotal trials
  • Regulatory and Commercial Strategies:  To position the product for optimal labeling and commercial potential
  • Passion and Dedication:  To benefit the patients and health care community